Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis

Peroxisome Proliferator-Activated Receptors (PPAR) are transcription factors suggested to be involved in inflammatory lesions of autoimmune encephalomyelitis and multiple sclerosis (MS). Our objective was to assess whether Natalizumab (NTZ) therapy is associated with alterations of PPAR expression i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferret-Sena, Véronique, Maia e Silva, Alexandra, Sena, Armando, Cavaleiro, Inês, Vale, José, Derudas, Bruno, Chinetti-Gbaguidi, Giulia, Staels, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203914/
https://www.ncbi.nlm.nih.gov/pubmed/28077943
http://dx.doi.org/10.1155/2016/5716415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203914/
https://www.ncbi.nlm.nih.gov/pubmed/28077943
http://dx.doi.org/10.1155/2016/5716415

Ejemplares similares